The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life?
about
Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].Epigenome-wide association data implicates DNA methylation-mediated genetic risk in psoriasis.Infliximab in the treatment of plaque type psoriasis.Cost-effectiveness and impact on quality of life of alefacept in the treatment of psoriasis.Biological markers in the etiology of psoriasis: Targeted treatment options.How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating the WHOQOL-100.
P2860
The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The promise and challenge of n ...... o they impact quality of life?
@ast
The promise and challenge of n ...... o they impact quality of life?
@en
type
label
The promise and challenge of n ...... o they impact quality of life?
@ast
The promise and challenge of n ...... o they impact quality of life?
@en
prefLabel
The promise and challenge of n ...... o they impact quality of life?
@ast
The promise and challenge of n ...... o they impact quality of life?
@en
P2860
P1433
P1476
The promise and challenge of n ...... o they impact quality of life?
@en
P2093
Stephen R Rapp
Steven R Feldman
P2860
P304
P356
10.1111/J.1396-0296.2004.04040.X
P577
2004-01-01T00:00:00Z